查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519389

2024-2032 年按技術、產品和服務、應用、最終用戶和地區分類的高通量篩選市場報告

High-throughput Screening Market Report by Technology, Products and Services, Applications, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球高通量篩選市場規模達252億美元。 3D細胞培養模型的採用增加、個人化藥物篩選分析的需求不斷成長以及基於CRISPR的篩選技術的應用不斷增加是推動高通量篩選市場成長的一些關鍵因素。

高通量篩選市場分析：

主要市場促進因素：擴大利用高溫超導技術來最大限度地縮短藥物製造所需的時間，這主要推動了市場的成長。此外，治療各種危及生命的疾病的新藥的開發也刺激了對高溫超導技術的需求。

主要市場趨勢：將人工智慧（AI）和機器學習（ML）等先進技術與高通量篩選相結合以促進自動化和快速資料處理是重要趨勢之一，促進了市場的成長。

地理景觀：高通量篩選市場預測報告提供了基於區域的詳細市場區隔和分析。其中包括北美、亞太地區、歐洲、拉丁美洲、中東和非洲。由於高通量篩選的日益採用、研發支出的增加以及組合化學和基因組學領域的不斷進步等因素，預計北美將在高通量篩選市場中佔據重要的市場佔有率。

競爭格局：一些領先的高通量篩選市場公司包括安捷倫科技公司、Aurora Biomed Inc.、Axxam SpA、Beckman Coulter Inc.（丹納赫公司）、Bio-RAD Laboratories Inc.、Charles River Laboratories International Inc.、康寧Incorporated、Luminex Corporation (DiaSorin)、Perkinelmer Inc.、Sygnature Discovery、Tecan Group Ltd. 和 Thermo Fisher Scientific 等。

挑戰與機會：高通量篩選市場的挑戰包括資料管理複雜性和對更多生理相關檢測模型的需求，而機會則在於自動化、人工智慧和晶片器官系統等先進技術，以提高效率和預測篩選過程。

高通量篩選市場趨勢：

高溫超導設施數量不斷增加

用於治療各種危及生命的疾病的新藥的開發主要推動了市場的成長。此外，為了最大限度地減少藥物製造所需時間而使用 HTS 的增加也促進了市場的成長。除此之外，高通量篩選（HTS）設施數量的不斷增加也催化了高通量篩選市場的近期價格上漲。這些中心的顯著優勢之一是研究人員、科學家、研究人員等之間的知識共享。此外，美國國立衛生研究院 (NIH) 計畫的歐洲對應計畫（稱為 EU-open-screen）為所有從事化學生物學的歐洲公司提供開放存取。高通量篩選（HTS）中心協會旨在提供有關藥物或標靶或整個過程的有用資訊。因此，開放取用為知識共享提供了更好的平台，有助於加速藥物開發進程，這可能會在未來幾年推動高通量篩選市場佔有率。

新型分子的不斷發展

各種傳染病患者病率的上升正在推動新型分子和疫苗的開發，這反過來又為高通量篩檢市場創造了積極的前景。此外，在藥物製造過程中對各種藥物和分子的精確和快速篩選的需求不斷增加，導致擴大採用自動化高通量篩選技術。此外，由於高通量篩選方法具有高靈敏度、自動化、樣品最小化以及檢測低背景訊號的能力等各種優勢，各種製藥和生物製品公司擴大採用高通量篩選方法，這支撐了高通量篩選方法的發展。根據美國國會預算辦公室公佈的資料，2021年，全球製藥業在研發上的支出接近2,000億美元，而2019年為8,300萬美元。為17.42 億美元，而2020 年為13.48 億美元。 此外，Bio-Rad Laboratories Inc. 2021 年的投資為8.796 億美元，而2020 年為8.003 億美元。量篩選分析中採用創新技術的能力，因而促進了市場成長。

技術進步

近年來，在機器人技術、自動化、資料分析和小型化不斷創新的推動下，高通量篩選（HTS）技術取得了顯著進展。此外，自動化和機器人技術的進步極大地提高了 HTS 工作流程的速度和效率。自動化液體處理系統、讀板機和機器人平台現在可以高精度和高通量地執行重複性任務，從而減少了手動干預的需要。此外，各種領先的生物技術公司也在投資研發活動，以引入改進的高溫超導方法，預計這將推動高通量篩選市場的收入。例如，2024 年2 月，生命科學分析技術領域的全球領導者SCIEX 在SLAS 2024 上推出了Echo MS+ 系統。相結合： SCIEX ZenoTOF 7600 或 Triple Quad 6500+ 系統透過強大的高通量篩選工作流程的擴展面板提供精確的定性和定量結果。

全球高通量篩選市場細分：

IMARC Group提供了全球高通量篩選市場報告每個細分市場的主要趨勢分析，以及 2024 年至 2032 年全球、區域和國家層面的預測。我們的報告根據技術、產品和服務、應用程式以及最終用戶對市場進行了分類。

按技術分類：

超高通量篩選

基於細胞的檢測

晶片實驗室

無標籤技術

該報告基於該技術對市場進行了詳細的細分和分析。這包括超高通量篩選、基於細胞的測定、晶片實驗室和無標記技術。

高通量篩選市場概況表明，各種製藥和生物技術公司擴大使用基於細胞的檢測方法。高通量篩選中基於細胞的測定利用活細胞作為化合物測試的生物讀數，能夠以高通量方式評估候選藥物對細胞功能、活力和表現型的影響，通常用於藥物發現和毒性篩選。螢光成像讀板儀測定已成為最常用的基於細胞的測定，因為其結果可見並且能夠以最小的體積進行測試。除此之外，超高通量篩選是最新技術，用於在更短的時間內提高產量。大多數公司正處於從 2D 細胞培養到 3D 細胞培養的過渡階段，因為 3D 細胞在自然環境和其他細胞相關操作中進行測試時顯示出更逼真的特性，有助於藥物設計和發現。

按產品和服務細分：

儀器

試劑和試劑盒

服務

高通量篩選市場報告根據產品和服務對市場進行了詳細的細分和分析。這包括儀器、試劑和套件以及服務。

高通量篩選依賴專用儀器，例如自動液體處理機、讀板器和機器人平台。這些儀器能夠快速處理、分配和分析微孔板形式的樣品，從而提高篩選實驗的效率和通量。而用於高通量篩選的試劑和試劑盒包括化合物庫、生化分析以及檢測試劑，例如螢光探針或酵素底物。這些經過最佳化，可與自動化系統和小型化測定格式相容，從而可以根據特定的生物標靶或途徑篩選大型化合物庫。

按應用分類：

目標識別和驗證

初級和次級篩選

毒理學評估

其他

該報告根據應用程式提供了詳細的市場細分和分析。這包括目標識別和驗證、初步和二次篩選、毒理學評估等。

目標識別和驗證涉及識別和驗證與疾病或生物過程有關的分子目標（例如蛋白質、基因或細胞途徑）。透過基因組學、蛋白質組學和生物資訊學等各種方法，識別並驗證潛在目標，以確保其相關性和可拖曳性以進行進一步研究。而在初級和二級篩選中，針對特定標靶或生物測定對大型化合物庫進行測試，以識別顯示活性或調節的初始命中。該方法涉及對命中化合物進行更詳細的表徵，以確認其活性、選擇性和效力。初級和次級篩選通常包括劑量反應研究、反篩選和次級測定，以驗證命中並優先考慮先導化合物最佳化和臨床前開發。

按最終用戶分類：

製藥和生物技術公司

學術和政府機構

合約研究組織

其他

該報告提供了基於最終用戶的詳細市場細分和分析。這包括製藥和生物技術公司、學術和政府機構、合約研究組織等。

根據IMARC的高通量篩選市場統計數據，製藥公司和政府組織的研發支出最近一直在增加，預計這將在預測期內推動市場成長。例如，全球領先的生命科學和診斷創新企業丹納赫公司(Danaher Corporation) 2021 年的研發投資為17.42 億美元，而2020 年為13.48 億美元。美元。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

市場研究報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。

由於高通量篩選的日益採用、研發支出的增加以及組合化學和基因組學領域的不斷進步等多種因素，預計北美將在高通量篩選市場中佔據重要的市場佔有率。除此之外，該地區知名市場參與者的存在也對高通量篩選市場前景產生正面影響。例如，2021 年8 月，Becton、Dickinson 和Company 推出了一種新型全自動高通量診斷系統，使用機器人技術和樣本管理軟體演算法，為核心實驗室和其他集中實驗室的傳染病分子檢測自動化設定了新標準在美國。此次發布使得 BD Onclarity HPV Assay 具有針對 BD COR 系統的擴展基因分型，可供高通量實驗室處理美國大多數持續感染人類乳突病毒 (HPV) 的子宮頸癌篩檢標本。

本報告回答的關鍵問題：

  • 迄今為止，全球高通量篩選市場的表現如何，未來幾年又將如何表現？
  • COVID-19 對全球高通量篩檢市場有何影響？
  • 主要區域市場有哪些？
  • 基於技術的市場區隔是什麼？
  • 基於產品和服務的市場區隔是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球高通量篩選市場的結構如何？
  • 產業競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球高通量篩選市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依技術

  • 超高通量篩選
    • 市場走向
    • 市場預測
  • 基於細胞的檢測
    • 市場走向
    • 市場預測
  • 晶片實驗室
    • 市場走向
    • 市場預測
  • 無標籤技術
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依產品與服務

  • 儀器
    • 市場走向
    • 市場預測
  • 試劑和試劑盒
    • 市場走向
    • 市場預測
  • 服務
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按應用

  • 目標識別和驗證
    • 市場走向
    • 市場預測
  • 初級和次級篩選
    • 市場走向
    • 市場預測
  • 毒理學評估
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 製藥和生物技術公司
    • 市場走向
    • 市場預測
  • 學術和政府機構
    • 市場走向
    • 市場預測
  • 合約研究組織
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Aurora Biomed Inc.
    • Axxam SpA
    • Beckman Coulter Inc. (Danaher Corporation)
    • Bio-RAD Laboratories Inc.
    • Charles River Laboratories International Inc.
    • Corning Incorporated
    • Luminex Corporation (DiaSorin)
    • Perkinelmer Inc.
    • Sygnature Discovery
    • Tecan Group Ltd.
    • Thermo Fisher Scientific
Product Code: SR112024A5704

The global high-throughput screening market size reached US$ 25.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 49.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032. The increased adoption of 3D cell culture models, growing demand for personalized medicine screening assays, and rising application of CRISPR-based screening techniques are some of the key factors driving high-throughput screening market growth.

High-Throughput Screening Market Analysis:

Major Market Drivers: The increasing utilization of HTS for minimizing the time required for manufacturing a drug is primarily driving the growth of the market. Furthermore, the development of new medicines for treating various life-threatening diseases is also catalyzing the demand for HTS techniques.

Key Market Trends: Integration of advanced technologies, such as artificial intelligence (AI) and machine learning (ML) with high-throughput screening to facilitate automation and fast data processing is one of the significant trends, augmenting the growth of the market.

Geographical Landscape: The high-throughput screening market forecast report has provided a detailed breakup and analysis of the market based on the region. This includes North America, Asia Pacific, Europe, Latin America, and Middle East and Africa. North America is expected to hold a significant market share in the high-throughput screening market owing to factors such as the increasing adoption of high-throughput screening, rising research and development expenditure, and the growing advances in combinatorial chemistry and the field of genomics.

Competitive Landscape: Some of the leading high-throughput screening market companies include Agilent Technologies Inc., Aurora Biomed Inc., Axxam S.p.A, Beckman Coulter Inc. (Danaher Corporation), Bio-RAD Laboratories Inc., Charles River Laboratories International Inc. Corning Incorporated, Luminex Corporation (DiaSorin), Perkinelmer Inc., Sygnature Discovery, Tecan Group Ltd., and Thermo Fisher Scientific, among many others.

Challenges and Opportunities: Challenges in the high-throughput screening market include data management complexities and the need for more physiologically relevant assay models, while opportunities lie in advancing technologies like automation, artificial intelligence, and organ-on-a-chip systems for more efficient and predictive screening processes.

High-Throughput Screening Market Trends:

Increasing Number of HTS Facilities

The development of new medicines for treating various life-threatening diseases is primarily driving the growth of the market. Furthermore, the rise in the utilization of HTS for minimizing the time required for manufacturing a drug is also contributing to the market growth. In addition to this, the escalating number of high-throughput screening (HTS) facilities is also catalyzing the high-throughput screening market's recent prices. One of the significant advantages of these centers is knowledge sharing among investigators, scientists, researchers, etc. For instance, the Columbia Genome Center offers high-quality molecular screening services for investigators throughout the Columbia University research community. Also, the European counterpart of the National Institutes of Health (NIH) program, known as EU-open-screen, provides open access to all European companies engaged in chemical biology. The association of high-throughput screening (HTS) centers is intended to provide useful information about the drug or target or the entire process. Thus, open access provides a better platform for knowledge sharing and can help accelerate the drug development process, which may drive the high-throughput screening market share in the coming years.

Rising Development of Novel Molecules

The rising prevalence of various infectious diseases is prompting the development of novel molecules and vaccines, which in turn is creating a positive outlook for the high-throughput screening market. Moreover, the escalating need for precise and quick screening of various drugs and molecules during the manufacturing of a drug is resulting in an increased adoption of automated high-throughput screening techniques. Furthermore, various pharmaceutical and biologic firms are increasingly adopting high-throughput screening methods on account of their various advantages, such as high sensitivity, automation, minimization of the sample, and the ability to detect low background signals, which is bolstering the high-throughput screening market demand. According to the data published by the Congressional Budget Office, in 2021, it was observed that pharmaceutical industries spent nearly US$ 200 Billion on research and development in 2020 globally, compared to US$ 83 Million in 2019. Similarly, Danaher Corporation invested US$ 1,742 Million in its research and development in 2021, as compared to US$ 1,348 Million in 2020. In addition, Bio-Rad Laboratories Inc. invested US$ 879.6 Million in 2021 as compared to US$ 800.3 Million in 2020. Thus, the increasing investment in research and development by the companies further increases their capabilities to adopt innovative technologies in high throughput screening assays, thereby increasing the market growth.

Technological Advancements

High-throughput screening (HTS) techniques have seen significant advancements in recent years, driven by the continuous innovations in robotics, automation, data analysis, and miniaturization. Moreover, advances in automation and robotics are extensively increasing the speed and efficiency of HTS workflows. Automated liquid handling systems, plate readers, and robotic platforms can now perform repetitive tasks with high precision and throughput, reducing the need for manual intervention. Additionally, various leading biotech companies are also investing in research and development activities to introduce improved HTS methods which are anticipated to propel the high-throughput screening market revenue. For instance, in February 2024, SCIEX, a global leader in life science analytical technologies, launched the Echo MS+ system at SLAS 2024. The system couples proprietary Acoustic Ejection Mass Spectrometry technology and Open Port Interface (OPI) sampling with the capabilities of either the SCIEX ZenoTOF 7600 or Triple Quad 6500+ system to deliver precise qualitative and quantitative results through an expanded panel of robust high-throughput screening workflows.

Global High-Throughput Screening Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global high-throughput screening market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on technology, products and services, applications, and end user.

Breakup by Technology:

Ultra-High-Throughput Screening

Cell-Based Assays

Lab-on-a-Chip

Label-Free Technology

The report has provided a detailed breakup and analysis of the market based on the technology. This includes ultra-high throughput screening, cell-based assays, lab-on-a-chip, and label-free technology.

The high-throughput screening market overview indicates that cell-based assays are increasingly being used by various pharmaceutical and biotech companies. Cell-based assays in high-throughput screening utilize live cells as the biological readout for compound testing, enabling the evaluation of drug candidates' effects on cellular function, viability, and phenotype in a high-throughput manner, often employed in drug discovery and toxicity screening. Fluorometric imaging plate reader assays have become the most used cell-based assays owing to visible results and their ability to test with the smallest of volumes. Besides this, ultra-high-throughput screening is the latest technology and is used for increased output in less time. A majority of companies are in a transition phase from 2D-cell cultures to 3D-cell cultures as 3D cells show more lifelike properties while testing in the natural environment and other cell-related manipulations, aided for drug design and discovery.

Breakup by Products and Services:

Instruments

Reagents and Kits

Services

The high-throughput screening market report has provided a detailed breakup and analysis of the market based on the products and services. This includes instruments, reagents and kits, and services.

High-throughput screening relies on specialized instruments, such as automated liquid handlers, plate readers, and robotic platforms. These instruments enable the rapid handling, dispensing, and analysis of samples in microplate formats, thereby increasing the efficiency and throughput of screening experiments. Whereas reagents and kits that are used in high-throughput screening include compound libraries, biochemical assays, and detection reagents such as fluorescent probes or enzyme substrates. These are optimized for compatibility with automated systems and miniaturized assay formats, allowing for the screening of large compound libraries against specific biological targets or pathways.

Breakup by Applications:

Target Identification and Validation

Primary and Secondary Screening

Toxicology Assessment

Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes target identification and validation, primary and secondary screening, toxicology assessment and others.

Target identification and validation involves identifying and validating molecular targets (such as proteins, genes, or cellular pathways) that are implicated in a disease or biological process. Through various methods, including genomics, proteomics, and bioinformatics, potential targets are identified and then validated to ensure their relevance and draggability for further investigation. Whereas in primary and secondary screening large libraries of compounds are tested against a specific target or biological assay to identify initial hits that show activity or modulation. This method involves a more detailed characterization of hit compounds to confirm their activity, selectivity, and potency. Primary and secondary screening typically includes dose-response studies, counter-screens, and secondary assays to validate hits and prioritize them for lead optimization and preclinical development.

Breakup by End User:

Pharmaceutical and Biotechnology Firms

Academic and Government Institutes

Contract Research Organizations

Others

The report has provided a detailed breakup and analysis of the market based on the end user. This includes pharmaceutical and biotechnology firms, academic and government institutes, contract research organizations, and others.

According to high-throughput screening market statistics by IMARC, the spending on research and development (R&D) by both pharmaceutical companies and government organizations has been increasing recently, which is anticipated to drive market growth over the forecast period. For instance, Danaher Corporation, a leading global life sciences and diagnostics innovator, invested US$ 1,742 Million in its research and development in 2021, as compared to US$ 1,348 Million in 2020. In addition, Bio-Rad Laboratories Inc. invested US$ 879.6 Million in 2021 as compared to US$ 800.3 Million in 2020. Thus, the huge investment by pharmaceuticals, biotech firms, and government institutions will continue to drive the market growth.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

North America is expected to hold a significant market share in the high-throughput screening market owing to various factors such as the increasing adoption of high-throughput screening, rising research and development expenditure, and the growing advances in combinatorial chemistry and the field of genomics. In addition to this, the presence of prominent market players in the region is also positively impacting the high-throughput screening market outlook. For instance, in August 2021, Becton, Dickinson, and Company launched a new, fully automated high-throughput diagnostic system using robotics and sample management software algorithms to set a new standard in automation for infectious disease molecular testing in core laboratories and other centralized laboratories in the United States. This launch made BD Onclarity HPV Assay with extended genotyping for the BD COR System available to the high-throughput labs for processing most cervical cancer screening specimens in the United States with persistent infection with human papillomavirus (HPV).

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.

Aurora Biomed Inc.

Axxam S.p.A

Beckman Coulter Inc. (Danaher Corporation)

Bio-RAD Laboratories Inc.

Charles River Laboratories International Inc.

Corning Incorporated

Luminex Corporation (DiaSorin)

Perkinelmer Inc.

Sygnature Discovery

Tecan Group Ltd

Thermo Fisher Scientific

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

High-Throughput Screening Market Recent Developments:

April 2024: Gordian Biotechnology introduced a high-throughput in vivo screening platform to discover therapies and better predict human outcomes for age-related diseases.

April 2024: Metrion Biosciences Limited and Enamine Ltd., announced that Metrion has enhanced its High Throughput Screening (HTS) services with the addition of access to Enamine's compound libraries.

February 2024: SCIEX, a global leader in life science analytical technologies, launched the Echo MS+ system at SLAS 2024. The system couples proprietary Acoustic Ejection Mass Spectrometry technology and Open Port Interface (OPI) sampling with the capabilities of either the SCIEX ZenoTOF 7600 or Triple Quad 6500+ system to deliver precise qualitative and quantitative results, through an expanded panel of robust high-throughput screening workflows.

Key Questions Answered in This Report:

  • How has the global high-throughput screening market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global high-throughput screening market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the products and services?
  • What is the breakup of the market based on the applications?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global high-throughput screening market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global High-throughput Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Ultra-High-Throughput Screening
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Cell-Based Assays
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Lab-on-a-Chip
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Label-Free Technology
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Products and Services

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Reagents and Kits
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Services
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Applications

  • 8.1 Target Identification and Validation
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Primary and Secondary Screening
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Toxicology Assessment
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biotechnology Firms
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Government Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organizations
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Aurora Biomed Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Axxam S.p.A
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Beckman Coulter Inc. (Danaher Corporation)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Charles River Laboratories International Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Corning Incorporated
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Luminex Corporation (DiaSorin)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 SWOT Analysis
    • 15.3.9 Perkinelmer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sygnature Discovery
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Tecan Group Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Thermo Fisher Scientific
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: High-throughput Screening Market: Major Drivers and Challenges
  • Figure 2: Global: High-throughput Screening Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: High-throughput Screening Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: High-throughput Screening Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: High-throughput Screening Market: Breakup by Products and Services (in %), 2023
  • Figure 6: Global: High-throughput Screening Market: Breakup by Applications (in %), 2023
  • Figure 7: Global: High-throughput Screening Market: Breakup by End User (in %), 2023
  • Figure 8: Global: High-throughput Screening Market: Breakup by Region (in %), 2023
  • Figure 9: Global: High-throughput Screening (Ultra-High-Throughput Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: High-throughput Screening (Ultra-High-Throughput Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: High-throughput Screening (Cell-Based Assays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: High-throughput Screening (Cell-Based Assays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: High-throughput Screening (Lab-on-a-Chip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: High-throughput Screening (Lab-on-a-Chip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: High-throughput Screening (Label-Free Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: High-throughput Screening (Label-Free Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: High-throughput Screening (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: High-throughput Screening (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: High-throughput Screening (Reagents and Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: High-throughput Screening (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: High-throughput Screening (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: High-throughput Screening (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: High-throughput Screening (Target Identification and Validation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: High-throughput Screening (Target Identification and Validation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: High-throughput Screening (Primary and Secondary Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: High-throughput Screening (Primary and Secondary Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: High-throughput Screening (Toxicology Assessment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: High-throughput Screening (Toxicology Assessment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: High-throughput Screening (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: High-throughput Screening (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: High-throughput Screening (Pharmaceutical and Biotechnology Firms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: High-throughput Screening (Pharmaceutical and Biotechnology Firms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: High-throughput Screening (Academic and Government Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: High-throughput Screening (Academic and Government Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: High-throughput Screening (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: High-throughput Screening (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: High-throughput Screening (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: High-throughput Screening (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: High-throughput Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: High-throughput Screening Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: High-throughput Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: High-throughput Screening Industry: SWOT Analysis
  • Figure 89: Global: High-throughput Screening Industry: Value Chain Analysis
  • Figure 90: Global: High-throughput Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: High-throughput Screening Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: High-throughput Screening Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 3: Global: High-throughput Screening Market Forecast: Breakup by Products and Services (in Million US$), 2024-2032
  • Table 4: Global: High-throughput Screening Market Forecast: Breakup by Applications (in Million US$), 2024-2032
  • Table 5: Global: High-throughput Screening Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: High-throughput Screening Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: High-throughput Screening Market: Competitive Structure
  • Table 8: Global: High-throughput Screening Market: Key Players